US 10,096,413

Application 15/328,258 · Granted Oct 9, 2018

Quenched alloy for rare earth magnet and a manufacturing method of rare earth magnet

Estimated expiration

September 21, 2035

8y 305d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTCN2015085555: Resource not found (404)
Earliest effective filing
Jul 30, 2015
+ 20 years
Jul 30, 2035
PTA +53d
Sep 21, 2035
No TD
—
Final
Sep 21, 2035

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
January 23, 2017
Earliest effective filing
July 30, 2015
Issue date
October 9, 2018
PTA
+53 days
Base expiry (before PTA)
July 30, 2035

July 30, 2015 + 20 years = July 30, 2035 + 53 PTA days = September 21, 2035

  • National stage entry of application PCTCN2015085555, filed Jul 30, 2015

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 15/328,258 · US 10,096,413

PatentReply compiles the prosecution history behind US 10,096,413: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US10096413

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.